このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
SMS Pharmaceuticals 過去の業績
過去 基準チ ェック /26
SMS Pharmaceuticalsの収益は年間平均-10.3%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間17% 6.7%割合で 増加しています。 SMS Pharmaceuticalsの自己資本利益率は9.3%であり、純利益率は7%です。
主要情報
-10.3%
収益成長率
-10.3%
EPS成長率
| Pharmaceuticals 業界の成長 | 17.5% |
| 収益成長率 | 6.7% |
| 株主資本利益率 | 9.3% |
| ネット・マージン | 7.0% |
| 前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It
Oct 28What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?
Oct 08Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?
Sep 17SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Aug 26SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Could Signal Some Risk
Aug 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Business Is Trailing The Market But Its Shares Aren't
Aug 08SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Looks Just Right
Jul 25収支内訳
収支内訳
SMS Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 24 | 7,093 | 498 | 641 | 0 |
| 31 Dec 23 | 6,129 | 361 | 615 | 0 |
| 30 Sep 23 | 6,002 | 288 | 598 | 0 |
| 30 Jun 23 | 5,930 | 150 | 571 | 0 |
| 31 Mar 23 | 5,221 | -71 | 560 | 0 |
| 31 Dec 22 | 4,335 | -42 | 535 | 0 |
| 30 Sep 22 | 4,060 | 9 | 532 | 0 |
| 30 Jun 22 | 4,211 | 259 | 517 | 0 |
| 31 Mar 22 | 5,199 | 622 | 515 | 0 |
| 31 Dec 21 | 6,348 | 789 | 499 | 0 |
| 30 Sep 21 | 6,612 | 911 | 475 | 0 |
| 30 Jun 21 | 6,172 | 791 | 442 | 0 |
| 31 Mar 21 | 5,632 | 625 | 415 | 0 |
| 31 Dec 20 | 4,911 | 458 | 405 | 0 |
| 30 Sep 20 | 4,226 | 319 | 398 | 0 |
| 30 Jun 20 | 4,130 | 308 | 386 | 0 |
| 31 Mar 20 | 4,143 | 316 | 410 | 0 |
| 31 Dec 19 | 4,206 | 386 | 398 | 0 |
| 30 Sep 19 | 4,412 | 405 | 389 | 0 |
| 30 Jun 19 | 4,606 | 406 | 366 | 0 |
| 31 Mar 19 | 4,667 | 400 | 372 | 0 |
| 31 Mar 18 | 4,639 | 317 | 343 | 0 |
| 31 Mar 17 | 4,388 | 285 | 288 | 0 |
| 31 Mar 16 | 6,032 | 409 | 406 | 0 |
| 31 Dec 15 | 5,902 | 391 | 579 | 0 |
| 30 Sep 15 | 5,828 | 396 | 566 | 0 |
| 30 Jun 15 | 5,651 | 343 | 330 | 0 |
| 31 Mar 15 | 5,793 | 352 | 533 | 0 |
| 31 Dec 14 | 5,730 | 358 | 504 | 0 |
| 30 Sep 14 | 5,624 | 327 | 493 | 0 |
| 30 Jun 14 | 5,567 | 326 | 282 | 0 |
| 31 Mar 14 | 5,180 | 204 | 455 | 0 |
| 31 Dec 13 | 3,976 | 686 | 372 | 0 |
| 30 Sep 13 | 3,396 | 430 | 350 | 0 |
| 30 Jun 13 | 2,771 | -792 | 187 | 0 |
質の高い収益: SMSPHARMAは 高品質の収益 を持っています。
利益率の向上: SMSPHARMA過去に利益を上げました。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: SMSPHARMAの収益は過去 5 年間で年間10.3%減少しました。
成長の加速: SMSPHARMAは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。
収益対業界: SMSPHARMA昨年収益を上げたため、昨年の収益成長をPharmaceuticals業界 ( 18% ) と比較することは困難です。
株主資本利益率
高いROE: SMSPHARMAの 自己資本利益率 ( 9.3% ) は 低い とみなされます。